>
Republicans Deserve to Lose, but Democrats Do Not Deserve to Win
The Download: UK DIGITAL ID THREATENS PRIVACY & "FREE" MONEY: THE COST OF UBI
BREAKING: O'Keefe Media Group Drops Talarico Tapes One Day Before Midterm Elections (VIDEO)
2026's Safest--And Least Safe--Cities in America
PRP vs Exosomes vs Stem Cells: Which Fits Your Condition?
SHOCKING: The Secret (Frantzve) Family Business
Microreactor Gets DOE Approval for Full Power Testing, Previously Contracts with Army...
Ford Fathom: Everything We Know About The Sub-$30,000 Affordable EV Truck
Love it or loathe it, AI is birthing a golden age of science
SpaceX has no competition -- Saurav Shroff, Starpath
Living computers forge a 'hive mind' and work together to outsmart AI
The Faraday duffle bag: A digital lifeline in a surveillance-saturated world
Delivery Robots Accused Of Scanning Customers' Faces, Sharing Biometric Data
FDA-Approval for Drill-Free Cavity Care May Be Imminent After Great Phase 3 Treatment Trial

•Rather than being a single disease, Alzheimer's has multiple different subtypes (e.g., those due to insulin resistance, nutritional deficiencies, inflammation, infections, or concussions), each of which requires a different treatments.
•Impaired blood circulation to the brain and lymphatic drainage from the brain are often the primary trigger which initiates the degenerative process seen in Alzheimer's disease.
•Factors which impair this circulation (e.g., poor sleep) hence roughly double the risk of dementia, while treatments which improve this circulation frequently produce remarkable improvements for cognitive decline and dementia.
•DMSO, an effective treatment for brain injuries like strokes is well suited to address many of the root causes of dementia and reverse the degenerative state dying neurons get trapped in. Because of this, there are many reports of it reversing dementia and clinical trials in both humans and animals corroborating these improvements.
•This article will review the actual causes of dementias like Alzheimer's and the forgotten therapies many have successful used to cure them.
Alzheimer's dementia is one of the greatest medical challenged our country faces (e.g., places an incredible burden upon society (e.g., last year it was estimated to cost the United States 360 billion dollars). Yet, despite spending billions for research each year, cures remain elusive, something many believe results from the flawed belief eliminating the amyloid plaques associated with Alzheimer's will fix it.
In turn, as I showed here:
Decades of amyloid therapies have never produced a beneficial therapy.
The newest "breakthrough" amyloid eliminating monoclonal antibodies, at best, slightly slow the progression of Alzheimer's while simultaneously causing a host of side effective including brain bleeding and swelling in over a quarter of recipients.
The entire amyloid industry rests upon a fraudulent study no one wanted to retract, likely due to how much was invested in the amyloid hypothesis.